Close this search box.

Ardena: Investment in Flow Cytometry unlocks the secrets of single cells

Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO), has announced a breakthrough investment in its Flow Cytometry services, greatly expanding their scientific capabilities.

“We can now provide our customers with much broader bio-analytical services,” explained Gerjan Kemperman, Ardena COO. “This expertise gives us the ability to unlock the enormous potential for information from single cells providing our clients with the full bio-analytical package,” he said.

This new capability is in large part thanks to the appointment of Arjan Kol at Ardena’s Bioanalysis centre in Assen, Netherlands. Arjan is an expert in Flow Cytometry, a fluorescence-based technology enabling high-throughput single cell measurements of multiple biological and functional parameters. It has various applications in novel drug discovery and development for areas such as immunology, oncology, molecular biology, infectious disease monitoring, bacteriology and virology.

“We can now perform highly sensitive measurements of preserved or fresh samples from a wide variety of biological matrices,” outlined Melloney Dröge, Business Unit Director at Ardena Assen, The Netherlands. “We can provide clients with single cell measurements of up to 14 parameters and fully automated measurements with consistent results from day to day,” she said.

Ardena is currently applying this expertise on new projects with leading players in the field providing analytical support at all stages of the drug development process, including for instance immunophenotyping and receptor occupancy assays, customized immunogenicity assays and PD analysis.

“Many clients, especially in the immunology field, now require cell level data not just data from fluids,” explained Arjan. “We can now provide flow cytometry as an integral part of our service offer, which is exciting for us and good for the progress of our clients’ drug development and clinical programs.”

About Ardena Group

The Ardena Group (’Ardena’) is a world-class Contract Development and Manufacturing Organization. Ardena assists pharmaceutical companies, from virtual biotech to big pharma, in bringing their valued molecules to the clinic and the market.

Ardena provides a comprehensive range of services from early drug substance development to finished dosage form, including: drug substance development & manufacturing; solid state research; drug product development & manufacturing; drug product packaging, labelling & supply; bioanalysis; dossier development and nanomedicine. For more information, please visit

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?


The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.